Skip to main content
QUCY
NASDAQ Life Sciences

Quantum Cyber Retains $5M Cash for Manufacturing, Amends Key IP License

Analysis by Wiseek AI
Sentiment info
Positive
Importance info
8
Price
$2.54
Mkt Cap
$55.78M
52W Low
$0.3
52W High
$4.93
Market data snapshot near publication time

Summary

Quantum Cyber N.V. amended its IP license agreement with BP United Inc., retaining a $5 million cash payment for its manufacturing operations and establishing a vesting schedule for consideration shares.


Key Events

  • $5 Million Cash Retained

    Quantum Cyber N.V. will retain a $5 million cash payment previously owed to BP United Inc., redirecting these funds towards ramping up its own manufacturing operations for licensed products.

  • IP License Agreement Amended

    The Intellectual Property License Agreement with BP United Inc. was amended, shifting from a contemplated Exclusive Supply Agreement to BP United providing manufacturing and consulting services.

  • Consideration Shares Vesting Schedule

    The Consideration Shares, which constitute the Upfront Consideration for the IP license, will now vest in four equal quarterly installments on September 30, 2026, March 31, 2027, June 30, 2027, and September 30, 2027.

  • Termination Rights Modified

    Quantum Cyber N.V. no longer has the right to terminate the Intellectual Property License Agreement without cause, limiting its flexibility in the partnership.


Analysis

Quantum Cyber N.V. has amended a material intellectual property license agreement, notably retaining a $5 million cash payment that was previously an obligation. For a company with a market capitalization of approximately $55 million and recent disclosures of 'going concern' issues, this $5 million cash retention (nearly 9% of market cap) is a significant positive for its liquidity and ability to fund the ramp-up of its new manufacturing operations. While the amendment also removes Quantum Cyber's right to terminate the agreement without cause, the immediate cash benefit for strategic execution outweighs this limitation.

At the time of this filing, QUCY was trading at $2.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $55.8M. The 52-week trading range was $0.30 to $4.93. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

QUCY - Latest Insights

QUCY
Jun 03, 2026, 8:53 AM EDT
Source: Wiseek News
Importance Score:
7
QUCY
Jun 03, 2026, 8:44 AM EDT
Filing Type: 8-K
Importance Score:
8
QUCY
Jun 02, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
QUCY
Jun 01, 2026, 5:19 PM EDT
Filing Type: DEF 14A
Importance Score:
9
QUCY
May 28, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
QUCY
May 26, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
9
QUCY
May 26, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
9
QUCY
May 22, 2026, 4:59 PM EDT
Filing Type: PRE 14A
Importance Score:
9
QUCY
May 22, 2026, 12:32 PM EDT
Filing Type: 144
Importance Score:
10
QUCY
May 18, 2026, 4:28 PM EDT
Filing Type: 144
Importance Score:
9